Yoshiki Sekijima

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

David Adams, Alejandra González‐Duarte, William O’Riordan et al. · New England Journal of Medicine · 2018 · 2.9K citations · Full text

Life Sciences, Molecular Biology, Pharmacology +14

Repurposing Diflunisal for Familial Amyloid Polyneuropathy

John L. Berk, Ole B. Suhr, Laura Obici et al. · JAMA · 2013 · 701 citations · Full text

Medicine, Neurology, Molecular Pathology +14

Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

Merrill D. Benson, Joel N. Buxbaum, David Eisenberg et al. · Amyloid · 2018 · 575 citations · Full text

Life Sciences, Biochemistry, Pathology +13

The Biological and Chemical Basis for Tissue-Selective Amyloid Disease

Yoshiki Sekijima, R. Luke Wiseman, Jeanne Matteson et al. · Cell · 2005 · 494 citations · Full text

Life Sciences, Biochemistry, Neuroscience +14

Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee

Merrill D. Benson, Joel N. Buxbaum, David Eisenberg et al. · Amyloid · 2020 · 407 citations · Full text

Life Sciences, Molecular Biology, Pathology +15